|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.82 CNY | +1.35% |
|
+6.63% | +6.81% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 24.7 | +33.01% | 7 | ||||||
| 61.47 | +91.25% | 16 | ||||||
| 4.639 | +59.49% | 15 | ||||||
| 2,976 | +17.54% | 10 | ||||||
| 33.22 | +59.46% | 12 | ||||||
| 327.88 | +42.96% | 8 | ||||||
| 124.21 | +37.47% | 9 | ||||||
| 47 | +15.99% | 6 | ||||||
| - | - | 1,415 | +205.62% | 1 | ||||
| 37.19 | +15.49% | 8 | ||||||
| 79.67 | +18.2% | 9 | ||||||
| 1,168.71 | +45.89% | 7 | ||||||
| 14.86 | +31.29% | 5 | ||||||
| 54.32 | +33.15% | 8 | ||||||
| - | 90 | +13.21% | 2 | |||||
| - | 5,100 | +35.28% | 2 | |||||
| Average | 722.43 | +47.21% | 8 | ||||||
| Weighted average by Cap. | 547.66 | +59.80% | 11 |
Select your edition
All financial news and data tailored to specific country editions
